Article

Oncologist Richard T. Silver on Receiving the MPN Hero Award

Richard Silver, an oncologist focused on rare blood diseases called myeloproliferative neoplasms was named an MPN Hero for Commitment to the Broader MPN Community for 2014.

Richard Silver, who was named an MPN Hero at this year's event, is an oncologist and professor of medicine and Director Emeritus of the Richard T. Silver, M.D. Myeloproliferative Neoplasm Center in New York City. He is an attending physician at New York Presbyterian Hospital and medical director of The Cancer Research and Treatment Fund, Inc. Silver was named an MPN Hero for Commitment to the Broader MPN Community.

Silver has written four books and more than 275 peer-reviewed articles, has been the principal investigator in multiple clinical trials, sponsored bi-annual patient-hematologist seminars, is the co-inventor of the BMB biopsy technique, and was instrumental in founding the MPN Center for Research and Therapy. In recognition of his work, patients and colleagues established The Richard T. Silver Distinguished Professor of Hematology/Oncology Chair and Visiting Professorship in the Department of Medicine.

You can learn more about the MPN Heroes at curetoday.com/events/mpn.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of a woman wearing a headband and glasses
Image of man.
Image of doctor.
CURE spoke with Andy Guinigundo to discuss the role that biomarkers play for patients with breast cancer.
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Image of doctor.
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.